There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - Senate

Short Titles as Introduced

Medicare Prescription Drug Price Negotiation Act of 2017

Official Titles

Official Titles - Senate

Official Titles as Introduced

A bill to amend part D of title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate covered part D drug prices on behalf of Medicare beneficiaries.


Actions Overview (1)

Date
01/05/2017 Introduced in Senate

All Actions (1)

Date
01/05/2017 Read twice and referred to the Committee on Finance.
Action By: Senate

Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
Senate Finance01/05/2017 Referred to

Related Bills (3)

A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-congress measures.

Subjects (6)

  • Health care costs and insurance
  • Inflation and prices
  • Medicare
  • Prescription drugs
  • Public contracts and procurement

Latest Summary (1)

There is one summary for S.41. View summaries

Shown Here:
Introduced in Senate (01/05/2017)

Medicare Prescription Drug Price Negotiation Act of 2017

This bill amends title XVIII (Medicare) of the Social Security Act to require the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits CMS from doing so.